Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aspirin 300mg dispersible tablets
0407010B0AAAEAE
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 9,980 |
|
Aspirin 300mg tablets
0407010B0AAAFAF
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 5,251 |
|
Aspirin 300mg gastro-resistant tablets
0407010B0AAA3A3
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 2,743 |
|
Aspirin 300mg suppositories
0407010B0AABEBE
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 7 |
|
Aspirin 150mg suppositories
0407010B0AABCBC
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 3 |
|
Acetylsalicylic acid mixture
0407010B0AAAWAW
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg effervescent tablets sugar free
0407010B0AACCCC
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg modified-release tablets
0407010B0AACGCG
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg orodispersible tablets sugar free
0407010B0AAANAN
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg/5ml oral liquid
0407010B0AAABAB
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 500mg effervescent tablets sugar free
0407010B0AAAGAG
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 500mg granules sachets sugar free
0407010B0AACBCB
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin powder
0407010B0AABRBR
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.